US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PomDoctor

0.3800

0.0000

Volume:56.48K

Turnover:20.79K

Market Cap:45.01M

PE:-0.69

High:0.3800

Open:0.3722

Low:0.3622

Close:0.3800

52wk High:6.43

52wk Low:0.1930

Shares:118.44M

Float Shares:5.00M

Volume Ratio:0.04

T/O Rate:1.13%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.5490

EPS(LYR):-0.5188

ROE:--

ROA:-32.56%

PB:-0.13

PE(LYR):-0.73

Loading ...

Overview Company News Filings

PomDoctor Limited Delays Annual 20-F Filing

Pomdoctor files Form 3 as director Bao Wenqing reports no beneficial ownership

Pomdoctor delays annual report filing, seeks extra time to finalize financial statements

Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading

MT Newswires Live

ADRs Close Lower; PomDoctor Ltd. Declines 23%

Pomdoctor replaces auditor Marcum Asia with HYYH CPA effective April 20

Pomdoctor files Form 3 as director Li Daxue Donnelly reports no holdings

PomDoctor Limited Announces Vice President Resignation Effective April 1, 2026

Pomdoctor says Vice President Dexiang Wei resigns effective April 1

Pomdoctor files Form 3 as director Jing Yuanyuan Crystal reports no beneficial ownership

Pomdoctor files Form 3 as CFO Li Xu reports beneficial ownership

Pomdoctor files Form 3 for VP, director Luo Guoji, reporting no securities owned

Polyplastics' DURACON(R) POM Adopted for Ground-breaking Crawler Transport System

Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem

Pomdoctor Limited Announces Strategic Upgrade, Focusing on "AI + Medical-Grade Smart Wearables" to Build a New Ecosystem for Full-Cycle Chronic Disease Management

THOMSON REUTERS

Class action lawsuit targets PomDoctor over alleged securities fraud between Oct. 9 and Dec. 11, 2025

ADRs Advance; PomDoctor Ltd. Climbs 74%

Rosen Law Firm Flags April 7 Lead Plaintiff Deadline in PomDoctor Securities Class Action

Class Action Lawsuit Targets PomDoctor Ltd. Over Alleged Securities Fraud

Rosen Law Firm Urges PomDoctor Investors to Seek Counsel Ahead of April 7 Lead Plaintiff Deadline

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/POM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"POM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"POM\",,,,,undefined,":{"symbol":"POM","market":"US","secType":"STK","nameCN":"PomDoctor","latestPrice":0.38,"timestamp":1777652297678,"preClose":0.38,"halted":0,"volume":56484,"delay":0,"changeRate":0,"floatShares":5000004,"shares":118444560,"eps":-0.549017,"marketStatus":"Trading","change":0,"latestTime":"05-01 12:28:01 EDT","open":0.3722,"high":0.38,"low":0.3622,"amount":20786.8830066,"amplitude":0.046842,"askPrice":0.3889,"askSize":100,"bidPrice":0.3622,"bidSize":10000,"shortable":3,"etf":0,"ttmEps":-0.549017,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1777665600000},"marketStatusCode":2,"adr":0,"listingDate":1759896000000,"exchange":"NASDAQ","adjPreClose":0.38,"postHourTrading":{"tag":"盘后","latestPrice":0.38,"preClose":0.38,"latestTime":"17:51 EDT","volume":15,"amount":5.6852,"timestamp":1777585885491,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.044457},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"POM\",,,,,undefined,":{"symbol":"POM","floatShares":5000004,"roa":"-32.56%","roe":"--","lyrEps":-0.518771,"volumeRatio":0.044457,"shares":118444560,"dividePrice":0,"high":0.38,"amplitude":0.046842,"preClose":0.38,"low":0.3622,"week52Low":0.193,"pbRate":"-0.13","psRate":"0.84","week52High":6.43,"institutionHeld":0.6205,"latestPrice":0.38,"committee":0.980198,"eps":-0.549017,"divideRate":0,"volume":56484,"delay":0,"ttmEps":-0.549017,"open":0.3722,"prevYearClose":0.2949,"prevWeekClose":0.3928,"prevMonthClose":0.38,"prevQuarterClose":0.2568,"fiveDayClose":0.3928,"twentyDayClose":0.2447,"sixtyDayClose":0.2306},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/POM\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"POM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"POM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/POM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"POM","date":"2026-04-30","current":-0.692328,"percent":0.457143,"low":-35.821387,"twenty":-25.958938,"median":-1.912329,"eighty":-1.381679,"high":-1.209478,"avg":-9.855914,"sd":12.224067,"marketCap":44036806},"quantilePoints":[{"date":"2025-10-10","current":-28.08946,"twenty":-26.346384,"median":-23.73177,"eighty":-12.43381,"marketCap":564969251},{"date":"2025-10-17","current":-25.958938,"twenty":-27.529376,"median":-25.953316,"eighty":-24.492433,"marketCap":522330062},{"date":"2025-10-24","current":-27.125928,"twenty":-27.238055,"median":-25.772572,"eighty":-24.836146,"marketCap":546018500},{"date":"2025-10-31","current":-32.013232,"twenty":-27.923178,"median":-26.542433,"eighty":-25.229622,"marketCap":645509940},{"date":"2025-11-07","current":-35.821387,"twenty":-31.941418,"median":-27.312807,"eighty":-25.43938,"marketCap":721312943},{"date":"2025-11-14","current":-20.985101,"twenty":-31.755441,"median":-27.438919,"eighty":-25.43938,"marketCap":424023043},{"date":"2025-11-21","current":-26.081236,"twenty":-31.546612,"median":-27.125928,"eighty":-25.185662,"marketCap":525883328},{"date":"2025-11-28","current":-25.273189,"twenty":-31.358539,"median":-26.69732,"eighty":-25.180844,"marketCap":511670265},{"date":"2025-12-05","current":-26.661858,"twenty":-30.715676,"median":-26.679589,"eighty":-25.208091,"marketCap":561415985},{"date":"2025-12-12","current":-2.158073,"twenty":-31.053988,"median":-26.69732,"eighty":-25.180844,"marketCap":45529178},{"date":"2025-12-19","current":-1.715925,"twenty":-30.611139,"median":-26.302634,"eighty":-23.907328,"marketCap":36290687},{"date":"2025-12-26","current":-1.95203,"twenty":-30.454437,"median":-26.020087,"eighty":-4.901837,"marketCap":41454766},{"date":"2026-01-02","current":-1.640406,"twenty":-29.257892,"median":-25.860133,"eighty":-2.141062,"marketCap":34928602},{"date":"2026-01-09","current":-1.729279,"twenty":-28.740158,"median":-25.425778,"eighty":-1.946053,"marketCap":36871054},{"date":"2026-01-16","current":-1.697767,"twenty":-28.349603,"median":-25.256593,"eighty":-1.819317,"marketCap":36290687},{"date":"2026-01-23","current":-1.636148,"twenty":-28.159927,"median":-25.188071,"eighty":-1.77506,"marketCap":34940446},{"date":"2026-01-30","current":-1.222508,"twenty":-27.840038,"median":-24.733658,"eighty":-1.723937,"marketCap":26199412},{"date":"2026-02-06","current":-1.21961,"twenty":-27.608521,"median":-23.052212,"eighty":-1.690555,"marketCap":26175724},{"date":"2026-02-13","current":-1.297697,"twenty":-27.413697,"median":-4.901837,"eighty":-1.639593,"marketCap":27999733},{"date":"2026-02-20","current":-1.289251,"twenty":-27.289193,"median":-2.366065,"eighty":-1.556644,"marketCap":27786538},{"date":"2026-02-27","current":-1.278849,"twenty":-27.230688,"median":-2.020338,"eighty":-1.386618,"marketCap":27833914},{"date":"2026-03-06","current":-1.414233,"twenty":-27.16801,"median":-1.95203,"eighty":-1.349156,"marketCap":30558085},{"date":"2026-03-13","current":-2.094273,"twenty":-27.021822,"median":-1.937086,"eighty":-1.364046,"marketCap":45398891},{"date":"2026-03-20","current":-1.981384,"twenty":-26.798326,"median":-1.967656,"eighty":-1.379044,"marketCap":42757630},{"date":"2026-03-27","current":-1.485475,"twenty":-26.683135,"median":-1.937086,"eighty":-1.386618,"marketCap":32003080},{"date":"2026-04-02","current":-1.360468,"twenty":-26.628518,"median":-1.893852,"eighty":-1.364233,"marketCap":29409196},{"date":"2026-04-10","current":-1.767669,"twenty":-26.418147,"median":-1.826527,"eighty":-1.361033,"marketCap":38517400},{"date":"2026-04-17","current":-2.067974,"twenty":-26.104338,"median":-1.843119,"eighty":-1.364488,"marketCap":45138318},{"date":"2026-04-24","current":-2.155153,"twenty":-26.056776,"median":-1.875376,"eighty":-1.378165,"marketCap":46997861},{"date":"2026-04-30","current":-2.019251,"twenty":-25.958938,"median":-1.912329,"eighty":-1.381679,"marketCap":44036806}],"updateTime":1777652881927},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"POM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631658602","title":"PomDoctor Limited Delays Annual 20-F Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2631658602","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631658602?lang=en_us&edition=fundamental","pubTime":"2026-04-30 21:14","pubTimestamp":1777554846,"startTime":"0","endTime":"0","summary":"PomDoctor Ltd. Unsponsored ADR ( ($POM) ) has released a notification of late filing. PomDoctor Limited, which trades in the U.S. via an unsponsore...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pomdoctor-limited-delays-annual-20-f-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pomdoctor-limited-delays-annual-20-f-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631680640","title":"Pomdoctor files Form 3 as director Bao Wenqing reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2631680640","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631680640?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:28","pubTimestamp":1777544914,"startTime":"0","endTime":"0","summary":"Pomdoctor filed an initial Form 3 disclosing Wenqing Bao as a director, dated March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL3fVrVQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631680648","title":"Pomdoctor delays annual report filing, seeks extra time to finalize financial statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2631680648","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631680648?lang=en_us&edition=fundamental","pubTime":"2026-04-30 18:28","pubTimestamp":1777544899,"startTime":"0","endTime":"0","summary":"Pomdoctor delayed filing annual report on Form 20-F for fiscal year ended Dec. 31, 2025.Form 20-F missed prescribed due date because company needed more time to review financial statements.Filing expected once consolidated financial statements become available.Pomdoctor indicated no significant change in results of operations versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 30, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL1HM2HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630558643","title":"Asian Equities Traded in the US as American Depositary Receipts Lower in Tuesday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2630558643","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630558643?lang=en_us&edition=fundamental","pubTime":"2026-04-28 22:57","pubTimestamp":1777388263,"startTime":"0","endTime":"0","summary":"Asian equities traded in the US as American depositary receipts were declining on Tuesday morning, down 1.4% to 2,747.76 on the S&P Asia 50 ADR Index.From North Asia, the gainers were led by medical services platform PomDoctor  and steel manufacturer Posco , which climbed 12% and 7.3% respectively.They were followed by consumer tech company Smart Share Global  and banking holding company Mizuho Financial Group , which rose 4.3% and 2.2% respectively.The decliners from North Asia were led by technology and healthcare company VisionSys AI  and Internet and data center service provider VNET Group , which dropped 26% and 6.1% respectively.They were followed by cloud service provider Kingsoft Cloud , which shed 6%.From South Asia, the gainers were led by pharmaceutical company Dr Reddy's Laboratories , which increased 0.8%.The decliners from South Asia were led by Sify Technologies , which fell 2%, followed by telecoms Telkom Indonesia  and PLDT , which were down 1.5% and 1.6%, respectively","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RDY.AU","LU1323998911.USD","BK4204","BK4608","LU0333810181.USD","BK4557","VSA","AFG","LU1102505762.USD","TLK","BK4115","LU0898667661.SGD","KCA/U","LU0431992006.USD","RDY","BK4117","BK4539","BK7062","SIFY","LU1366334651.USD","BK4505","IE00BYTNYM70.SGD","LU1366334578.USD","LU0791590937.USD","LU1805238398.USD","LU2087589342.USD","LU1267930656.SGD","BK4526","LU1508157978.USD","MFG.AU","LU0791591158.USD","BK4132","BK4175","PKX","BK4596","VNET","LU0708995666.HKD","BK4535","BK4007","LU0541502299.USD","INFY","PHI","LU0197229882.USD","EM","POM","BK4532","BK4563","MFG","KC","BK7016"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630831700","title":"ADRs Close Lower; PomDoctor Ltd. Declines 23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630831700","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630831700?lang=en_us&edition=fundamental","pubTime":"2026-04-28 04:30","pubTimestamp":1777321800,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed lower on Monday, as the S&P/BNY Mellon index of American depositary receipts dropped 0.3% to 257.39.The European index fell 0.6% to 223.93. The Asian index held steady at 344.43. The Latin American index fell 0.7% to 293.29, while the emerging-markets index dropped 0.2% to 601.24.PomDoctor Ltd., based in China, posted the largest decline, cratering 23% to 30 cents, followed by shares of Israel's Scinai Immunotherapeutics Ltd., which plunged 19% to 60 cents. Shares of Hong Kong-based Lion Group Holding Ltd. plunged 13% to 92 cents.China's VisionSys AI Inc. was the biggest leader during the session, soaring 33% to $1.10, and United Kingdom-based Wing Yip Food Holdings Group Ltd. jumped 14% to 74 cents. Akso Health Group, which is based in China, rounded out the top three leaders on Monday, with shares jumping 14% to $2.31.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629775646","title":"Pomdoctor replaces auditor Marcum Asia with HYYH CPA effective April 20","url":"https://stock-news.laohu8.com/highlight/detail?id=2629775646","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629775646?lang=en_us&edition=fundamental","pubTime":"2026-04-21 04:02","pubTimestamp":1776715373,"startTime":"0","endTime":"0","summary":"Pomdoctor dismissed Marcum Asia CPAs as independent registered public accounting firm effective April 20, 2026.HYYH CPA was appointed effective April 20, 2026 to audit consolidated financial statements for year ended Dec. 31, 2025.Marcum audit opinions for fiscal years 2023 and 2024 were not adverse or disclaimed.Prior disclosures cited material weaknesses in internal control over financial reporting tied to US GAAP and SEC reporting capability.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely respo","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL9m6Vfb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627494299","title":"Pomdoctor files Form 3 as director Li Daxue Donnelly reports no holdings","url":"https://stock-news.laohu8.com/highlight/detail?id=2627494299","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627494299?lang=en_us&edition=fundamental","pubTime":"2026-04-16 18:07","pubTimestamp":1776334062,"startTime":"0","endTime":"0","summary":"Pomdoctor filed Form 3 naming Li Daxue Donnelly as a director on March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL3bh6sm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625478709","title":"PomDoctor Limited Announces Vice President Resignation Effective April 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2625478709","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625478709?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:57","pubTimestamp":1775656677,"startTime":"0","endTime":"0","summary":"An announcement from PomDoctor Ltd. Unsponsored ADR ( ($POM) ) is now available. PomDoctor Limited, the Guangzhou-based foreign private issuer whos...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/pomdoctor-limited-announces-vice-president-resignation-effective-april-1-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/pomdoctor-limited-announces-vice-president-resignation-effective-april-1-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625944081","title":"Pomdoctor says Vice President Dexiang Wei resigns effective April 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2625944081","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625944081?lang=en_us&edition=fundamental","pubTime":"2026-04-08 21:27","pubTimestamp":1775654862,"startTime":"0","endTime":"0","summary":"Departure was not tied to any disagreement with board over operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL1v8hyk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624654568","title":"Pomdoctor files Form 3 as director Jing Yuanyuan Crystal reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2624654568","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624654568?lang=en_us&edition=fundamental","pubTime":"2026-04-03 18:46","pubTimestamp":1775213169,"startTime":"0","endTime":"0","summary":"Pomdoctor Form 3 filing identified Jing Yuanyuan Crystal as a director as of March 18, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL4CLNsY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624801654","title":"Pomdoctor files Form 3 as CFO Li Xu reports beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2624801654","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624801654?lang=en_us&edition=fundamental","pubTime":"2026-04-03 18:44","pubTimestamp":1775213059,"startTime":"0","endTime":"0","summary":"Pomdoctor CFO Li Xu filed an initial Form 3 reporting indirect ownership of Class B ordinary shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260403:nNDL6mLrV8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624155492","title":"Pomdoctor files Form 3 for VP, director Luo Guoji, reporting no securities owned","url":"https://stock-news.laohu8.com/highlight/detail?id=2624155492","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624155492?lang=en_us&edition=fundamental","pubTime":"2026-04-01 07:55","pubTimestamp":1775001334,"startTime":"0","endTime":"0","summary":"Pomdoctor filed an initial Form 3 disclosing Luo Guoji as vice president.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pomdoctor Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nNDL6gs3Pn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622804160","title":"Polyplastics' DURACON(R) POM Adopted for Ground-breaking Crawler Transport System","url":"https://stock-news.laohu8.com/highlight/detail?id=2622804160","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622804160?lang=en_us&edition=fundamental","pubTime":"2026-03-25 13:00","pubTimestamp":1774414800,"startTime":"0","endTime":"0","summary":"TOKYO, March 25, 2026 /PRNewswire/ -- Polyplastics Co., Ltd.'s DURACON POM resin has been selected for use in a unique crawler track transport system developed by Tokyo-based CuboRex Co., Ltd., a leading supplier of innovative mobility solutions. The unique transport system, which significantly improves work efficiency at factory and construction sites compared to conventional caster-equipped carts, includes a structural crawler covering made of DURACON POM.DURACON POM was selected for the crawler's white components. It was chosen for its high load-bearing capacity, providing the strength to withstand heavy-duty material handling at manufacturing sites. POM also boasts excellent friction properties, delivering stable performance in both static and dynamic friction. It offers durability and reliability, and meets destruction criteria even in harsh field environments. DURACON POM was adopted as an optimal solution following comparative testing with other resins such as PA.This case study","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/polyplastics-duraconr-pom-adopted-for-ground-breaking-crawler-transport-system-302724189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4232","BK4175","POM","BK4022","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619194908","title":"Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=2619194908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619194908?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403224,"startTime":"0","endTime":"0","summary":"Pomdoctor Ltd. Plans R&D and Deployment of AI-Powered Medical-Grade Wearables to Build a Closed-Loop, Full-Cycle Chronic Disease Management Ecosystem. Pomdoctor Ltd. announced plans to upgrade its strategy around AI and medical-grade smart wearables to support full-cycle chronic disease management. The company said it will accelerate R&D and scenario-based deployment to build a closed-loop ecosystem integrating devices, data, algorithms and services. Planned actions include developing medical-grade wearable devices for continuous physiological monitoring, building an AI-powered management system based on clinical guidelines to support risk monitoring and doctor-patient collaboration, and integrating these tools with its internet hospital platform, pharmaceutical supply chain and chronic disease service infrastructure to deliver monitoring, early warning, intervention and follow-up services. Pomdoctor said it intends to carry out R&D and commercialization in compliance with applicable m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nNDL1LSH6x:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4175","POM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619619499","title":"Pomdoctor Limited Announces Strategic Upgrade, Focusing on \"AI + Medical-Grade Smart Wearables\" to Build a New Ecosystem for Full-Cycle Chronic Disease Management","url":"https://stock-news.laohu8.com/highlight/detail?id=2619619499","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619619499?lang=en_us&edition=fundamental","pubTime":"2026-03-13 20:00","pubTimestamp":1773403202,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260313:nTUA4ZDC36:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619153696","title":"Class action lawsuit targets PomDoctor over alleged securities fraud between Oct. 9 and Dec. 11, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2619153696","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619153696?lang=en_us&edition=fundamental","pubTime":"2026-03-13 00:01","pubTimestamp":1773331289,"startTime":"0","endTime":"0","summary":"A securities class action lawsuit has been filed against PomDoctor and certain officers, alleging violations of U.S. federal securities laws. The suit seeks damages for investors who bought or acquired PomDoctor securities between Oct. 9, 2025 and Dec. 11, 2025. The complaint alleges PomDoctor was tied to a fraudulent stock promotion scheme involving social media misinformation and impersonated financial professionals. It also alleges insiders or affiliates used offshore or nominee accounts to coordinate share sales during a period of alleged price inflation.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL5ZZmTm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","BK4112","IE00B3QW5Z07.USD","LU2210150020.SGD","SG9999014005.SGD","BK4175","SG9999014021.USD","BK4585","LU2210149790.SGD","POM","SG9999014039.USD","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","LU0314104364.USD","LU2095319765.USD","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618728056","title":"ADRs Advance; PomDoctor Ltd. Climbs 74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618728056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618728056?lang=en_us&edition=fundamental","pubTime":"2026-03-10 04:30","pubTimestamp":1773088200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American depositary receipts gained 1.6% to 247.88.The European index increased 1.3% to 219.82. The Asian index added 1.8% to 325.53. The Latin American index rose 2.1% to 273.04, while the emerging-markets index increased 2.2% to 553.19.China's PomDoctor Ltd. was the biggest leader during the session, soaring 74% to 44 cents, and China-based XChange TEC.INC soared 35% to $1.05. Turbo Energy S.A., which is based in Spain, rounded out the top three leaders on Monday, with shares soaring 34% to $5.05.Huize Holding Ltd., based in China, posted the largest decline, plunging 14% to $1.63, followed by shares of China's Jinxin Technology Holding Co., which tumbled 13% to 42 cents. Shares of Hong Kong-based Yunji Inc. tumbled 12% to $1.55.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616379186","title":"Rosen Law Firm Flags April 7 Lead Plaintiff Deadline in PomDoctor Securities Class Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2616379186","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616379186?lang=en_us&edition=fundamental","pubTime":"2026-03-04 04:23","pubTimestamp":1772569400,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against PomDoctor Ltd. on behalf of investors who bought shares between Oct. 9, 2025 and Dec. 11, 2025. The suit alleges the company made misleading statements and omissions by failing to disclose an alleged stock promotion scheme, purported use of offshore or nominee accounts to dump shares during an inflation campaign, and artificial trading and rumors affecting the stock price. An April 7, 2026 deadline has been set for investors seeking to be appointed lead plaintiff.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL1QbPhp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","LU2095319765.USD","IE00BGHQF748.EUR","BK4175","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014039.USD","BK4588","BK4112","IE00BKPKM429.USD","LU2210149790.SGD","NDAQ","LU2210150020.SGD","POM","IE00B3QW5Z07.USD","SG9999014013.SGD","SG9999014005.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616373784","title":"Class Action Lawsuit Targets PomDoctor Ltd. Over Alleged Securities Fraud","url":"https://stock-news.laohu8.com/highlight/detail?id=2616373784","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616373784?lang=en_us&edition=fundamental","pubTime":"2026-03-04 02:48","pubTimestamp":1772563719,"startTime":"0","endTime":"0","summary":"A class action lawsuit has been filed against PomDoctor Ltd. in connection with alleged securities fraud and other unlawful business practices. The suit focuses on claims that the company and certain officers or directors were involved in an illicit pump-and-dump promotion scheme that preceded a sharp rise in the stock to $6.09 and a subsequent plunge of about 91% to $0.50 on Dec. 10, 2025. Investors who bought PomDoctor securities during the class period have until April 6, 2026, to seek appointment as lead plaintiff.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL657Nxz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","SG9999014013.SGD","SG9999014005.SGD","BK4112","BK4585","LU0314104364.USD","SG9999014039.USD","SG9999014021.USD","LU2095319765.USD","IE00BKPKM429.USD","BK4588","POM","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","IE00B64PRP62.GBP","BK4175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614553190","title":"Rosen Law Firm Urges PomDoctor Investors to Seek Counsel Ahead of April 7 Lead Plaintiff Deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2614553190","media":"Reuters","labels":["policyRegulatory","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614553190?lang=en_us&edition=fundamental","pubTime":"2026-02-26 04:50","pubTimestamp":1772052654,"startTime":"0","endTime":"0","summary":"A securities class action has been filed against PomDoctor Ltd. on behalf of investors who bought shares between Oct. 9, 2025 and Dec. 11, 2025. The suit alleges the company made misleading statements and omissions tied to an alleged stock promotion scheme, including social media misinformation, insider or affiliate share dumping through offshore or nominee accounts, and inadequate disclosure of purported artificial trading activity. The deadline to seek appointment as lead plaintiff is April 7, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLc1FSz1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["POM","BK4175"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}